Altered GABAergic neurotransmission in mice lacking dopamine D2 receptors

Molecular and Cellular Neuroscience

Volumn 25, Issue 4, 2004, Pages 732-741

  An, Juan Ji ^a,b   Bae, Mi Hyun ^a,b   Cho, Sang Rae ^a,b,e   Lee, Soo Hyun ^a,b,f   Choi, Seong Hoon ^a,b   Lee, Bae Hwan ^b   Shin, Hee Sup ^c   Kim, Yong Nyun ^a,b   Park, Kye Won ^a,b,g   Borrelli, Emiliana ^d   Baik, Ja Hyun ^a  

^a Korea University   (South Korea)

^b Yonsei University   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e CHA University   (South Korea)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; BICUCULLINE; DOPAMINE 2 RECEPTOR; ENKEPHALIN; GLUTAMATE DECARBOXYLASE; IMMEDIATE EARLY PROTEIN; MUSCIMOL; SACLOFEN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMEDIATE EARLY GENE; IN SITU HYBRIDIZATION; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHYTHM; SEIZURE;

ANIMALS; BASAL GANGLIA; BRAIN CHEMISTRY; DOPAMINE; ELECTROENCEPHALOGRAPHY; ENKEPHALINS; GABA AGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; MALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NEURAL INHIBITION; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-A; SEIZURES; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 11144356288     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2003.12.010     Document Type: Article

References (33)

1. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits; neural substrates of parallel processing. Trends Neurosci. 13:1990;266-272.
2. Aoyama S., Kase H., Borrelli E. Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist. J. Neurosci. 20:2000;5848-5852.
3. Baik J.H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., Le Meur M., Borrelli E. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature. 377:1995;424-428.
4. Bartholini G., Scatton B., Zivkovic B., Lloyd K.G. GABA receptor agonists and extrapyramidal motor function: therapeutic implications for Parkinson's disease. Adv. Neurol. 45:1987;79-83.
5. Baufreton J., Garret M., Dovero S., Dufy B., Bioulac B., Taupignon A. Activation of GABA(A) receptors in subthalamic neurons in vitro: properties of native receptors and inhibition mechanisms. J. Neurophysiol. 86:2001;75-85.
6. Cole A.J., Bhat R.V., Patt C., Worley P.F., Baraban J.M. D1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J. Neurochem. 58:1992;1420-1426.
7. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15:1992;133-139.
8. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J. Jr., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
9. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:1990;244-254.
10. Hornykiewicz O. Dopamine and brain function. Pharmacol. Rev. 18:1966;925-964.
11. Irifune M., Sato T., Kamata Y., Nishikawa T., Dohi T., Kawahara M. Evidence for GABA(A) receptor agonistic properties of ketamine: convulsive and anesthetic behavioral models in mice. Anesth. Analg. 91:2000;230-236.
12. Jung H.Y., Kang U.G., Joo Y.H., Cho S.C., Jeon S.H., Park J.B., Kim Y.S. Electroconvulsive shock does not induce c-fos and junB, but TIS1 and TIS8/zif-268, in neonatal rat hippocampus. Brain Res. Dev. Brain Res. 108:1998;303-306.
13. Kang H.J., Song M.R., Lee S.K., Shin E.C., Choi Y.H., Kim S.J., Lee J.W., Lee M.O. Retinoic acid and its receptors repress the expression and transactivation functions of Nur77: a possible mechanism for the inhibition of apoptosis by retinoic acid. Exp. Cell. Res. 256:2000;545-554.
14. Kultas-Ilinsky K., Leontiev V., Whiting P.J. Expression of 10 GABA(A) receptor subunit messenger RNAs in the motor-related thalamic nuclei and basal ganglia of Macaca mulatta studied with in situ hybridization histochemistry. Neuroscience. 85:1998;179-204.
15. Levy R., Lang A.E., Dostrovsky J.O., Pahapill P., Romas J., Saint-Cyr J., Hutchison W.D., Lozano A.M. Lidocaine and muscimol microinjections in subthalamic nucleus reverse Parkinsonian symptoms. Brain. 124:2001;2105-2118.
16. Luo J., Kaplitt M.G., Fitzsimons H.L., Zuzga D.S., Liu Y., Oshinsky M.L., During M.J. Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science. 298:2002;425-429.
17. Milbrandt J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science. 238:1987;797-799.
18. Milbrandt J. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron. 1:1988;183-188.
19. Moratalla R., Robertson H.A., Graybiel A.M. Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum. J. Neurosci. 12:1992;2609-2622.
20. Nakanishi H., Kita H., Kitai S.T. Electrical properties of rat subthalamic neurons in an in vitro slice preparation. Brain Res. 437:1987;35-44.
21. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., Hyman S.E. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. U. S. A. 89:1992;4270-4274.
22. Paladini C.A., Tepper J.M. GABA(A) and GABA(B) antagonists differentially affect the ring pattern of substantia nigra dopaminergic neurons in vivo. Synapse. 32:1999;165-176.
23. Paladini C.A., Celada P., Tepper J.M. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo. Neuroscience. 89:1999;799-812.
24. Perez de la Mora M., Ferre S., Fuxe K. GABA-dopamine receptor-receptor interactions in neostriatal membranes of the rat. Neurochem. Res. 22:1997;1051-1054.
25. Picetti R., Saiardi A., Abdel Samad T., Bozzi Y., Baik J.-H., Borrelli E. Dopamine D2 receptors in signal transduction and behavior. Crit. Rev. Neurobiol. 11:1997;121-142.
26. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
27. 3H]flunitrazepam autoradiography. Brain Res. 531:1990;95-104.
28. Soghomonian J.J., Chesselet M.F. GABA in Basal Ganglia, in GABA in the Nervous System: The View at Fifty Years. 2000;265-291 Lippincott William and Wilkins, Philadelphia.
29. A receptor balance by functional mesencephalic dopaminergic grafts in mice with hereditary parkinsonism. Exp. Neurol. 157:1999;259-267.
30. Steiner H., Gerfen C.R. Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons. Neuroscience. 88:1999;795-810.
31. 3H]muscimol binding in the rat hippocampus: a quantitative autoradiographic study. Neuroscience. 59:1994;817-826.
32. Watson M.A., Milbrandt J. Expression of the nerve growth factor-regulated NGFI-A and NGFI-B genes in the developing rat. Development. 110:1990;173-183.
33. Wichmann T., Kliem M.A., DeLong M.R. Exp. Neurol. 167:2001;410-424.